The tissue kallikreins are serine proteases encoded by highly conserved multi-gene families. The rodent kallikrein (KLK) families are particularly large, consisting of 13 -26 genes clustered in one chromosomal locus. It has been recently recognised that the human KLK gene family is of a similar size (15 genes) with the identification of another 12 related genes (KLK4-KLK15) within and adjacent to the original human KLK locus (KLK1-3) on chromosome 19q13.4. The structural organisation and size of these new genes is similar to that of other KLK genes except for additional exons encoding 5' or 3' untranslated regions. Moreover, many of these genes have multiple mRNA transcripts, a trait not observed with rodent genes. Unlike all other kallikreins, the KLK4-KLK15 encoded proteases are less related (25-44%) and do not contain a conventional kallikrein loop. Clusters of genes exhibit high prostatic (KLK2-4, KLK15) or pancreatic (KLK6-13) expression, suggesting evolutionary conservation of elements conferring tissue specificity. These genes are also expressed, to varying degrees, in a wider range of tissues suggesting a functional involvement of these newer human kallikrein proteases in a diverse range of physiological processes.
. Although highly conserved structurally, their known or predicted enzymic functions are specific and distinct from one another. They also share a wide range of expression patterns that likely indicate involvement in a diverse range of physiological processes (Bhoola et al., 1992; Clements, 1997; Rittenhouse et al., 1998; .
In contrast to the rodent tissue kallikrein (KLK) gene families, the human KLK gene family appeared to consist of just three genes -KLK1 encoding tissue kallikrein, KLK2 encoding glandular kallikrein and KLK3, which encodes prostate-specific antigen or PSA (Riegman et al., 1992; Clements, 1994) . These enzymes play important roles in the (patho)physiology of the kidney, pancreas and brain and cardiovascular, respiratory, gastrointestinal and reproductive systems (tissue kallikrein), prostate (PSA and K2) and breast (PSA) (Bhoola et al., 1992; Clements, 1997; Rittenhouse et al., 1998; Black and Diamandis, 2000) . Recently, several groups have identified other human serine proteases with homology to tissue kallikrein or PSA (Dihanich and Speiss, 1994; Hansson et al., 1994; Anisowicz et al., 1996; Liu et al., 1996; Little et al., 1997; Yamashiro et al., 1997; Yoshida et al., 1998a,b; Brattsand and Egelrud, 1999; Nelson et al., 1999; Stephenson et al., 1999; Tanimoto et al., 1999; Underwood et al., 1999; Hu et al., 2000; Mitsui et al., 2000; Diamandis 1999, 2000; Yousef et al., 1999a-c; 2000b-e) . All these genes were clustered at the human KLK locus on chromosome 19q13.4, thus expanding the human KLK gene family to at least 15 genes (Stephenson et al., 1999; Gan et al., 2000; Harvey et al., 2000; Yousef et al., 1999a Yousef et al., , 2000a . In this review, we summarise briefly the current knowledge on the structure and function of these genes, their genomic organisation, sites of expression and known or predicted physiological roles.
The Human KLK Locus at Proximal 19q13.4
The first three characterised human KLK genes -KLK1, KLK2 and KLK3 -were localised in a cluster to a 60 kilobase region at q13.3 -13.4 on chromosome 19 (Riegman et al., 1992; Stephenson et al., 1999) . This region is syntenic to the locus on mouse chromosome 7 where the mouse KLK gene family cluster is localised, further emphasising evolutionary similarities between these families (Howles et al., 1984; Evans et al., 1987) . However, the
Introduction
The tissue kallikreins are a subgroup of serine proteasesw that are characterised by their homology to true tissue kallikrein, encoded by the KLK1 gene (Clements, 1989 (Clements, , 1997 Bhoola et al., 1992) . Typically, they share a high degree of sequence and structural similarity and, at least in three species -mouse, rat and man -the genes are clustered together at one locus (Evans et al., 1987; Southard-Smith et al., 1994; Kurtz and St.Lezin, 1992;  striking difference between the mouse (and rat) and human KLK families was their size. The rodent families are large consisting of 13 -26 genes (Evans et al., 1987; Wines et al., 1989) ; the rat family is also clustered in one locus on rat chromosome 1 (Kurtz and St.Lezin, 1992; Southard-Smith et al., 1994) . Thus, by comparison, it appeared logical that the human KLK family may also contain more genes specifically within, or adjacent to, the original KLK cluster on 19q13.3 -13.4. Early genomic Southern blot analyses presented conflicting results with most groups suggesting there were only 3 -4 genes (Baker and Shine, 1985; Fukushima et al., 1985; Evans et al., 1988; Riegman et al., 1989) . However, Southern blot analyses of a human genomic library, using a monkey KLK cDNA probe with 92 -95% homology to human KLK cDNAs, indicated that there may be as many as 19 human KLK genes (Murray et al., 1990) .
Subsequently, several newly characterised human serine proteases -Protease M/neurosin/zyme, normal epithelial cell-specific 1 (Nes 1), trypsin-like serine protease (TLSP), stratum corneum chymotryptic enzyme (SCCE), and neuropsin -were identified to have some homology (~40%) to tissue kallikrein or PSA (Hansson et al., 1994; Anisowicz et al., 1996; Liu et al., 1996; Little et al., 1997; Yamashiro et al., 1997; Yoshida et al., 1998a,b) . Although these enzymes are less related than tissue kallikrein, K2 and PSA (62 -77%) are to each other, two of the encoding genes were localised by FISH analysis to 19q13.3 -13.4, in the vicinity of the KLK locus (Anisowicz et al., 1996; Little et al., 1997; Luo et al., 1998) . This suggested that indeed there were other serine protease genes in this region but that they were less related to the KLK1-3 encoded proteases in sharp comparison to the high conservation observed between the rodent kallikreins (70 -85%) (Evans et al., 1987; Wines et al., 1989) .
Recently, both the availability of the draft sequence for this region from the Human Genome Sequencing Project (at Lawrence Livermore National Laboratory, California, USA) and physical mapping has allowed the identification of 12 additional kallikrein-related genes (KLK4 -15) within a 320 kilobase region that encompasses the original KLK locus (Gan et al., 2000; Harvey et al., 2000; Yousef et al., 1999a Yousef et al., , 2000a . Although many of these new genes/proteases are known by a variety of designations (see above and Table 1 ), the Human Genome Nomenclature Committee recently approved the use of the consistent KLK nomenclature to describe these genes . KLK4 -14 lie telomeric of the original locus and are transcribed telomere to centromere in the same direction as KLK1 (Figure 1 ). KLK15 lies between KLK1 and KLK3 and is also transcribed in the same direction as KLK1. KLK2 and KLK3 are the only two genes in the locus that are transcribed in the opposite direction -centromere to telomere. Like the rodent families that contain 3 (rat) to 10 (mouse) pseudogenes (Berg et al., 1992) , 5 pseudogene sequences have been identified surrounding the KLK3-KLK2-KLK4 cluster at the cen-6 J.Clements et al. The Northern blot expression patterns are mostly from tissues except for the cell line, colorectal adenocarcinoma, whereas the RT-PCR patterns are from tissues and carcinoma cell lines; (᭜) represents carcinoma cell lines. All references used in the preparation of this tromeric end of the locus (Stephenson et al., 1999; Gan et al., 2000) . The locus lies between intervals D19S425 to D19S418 at proximal q13.4. Specific microsatellite markers that are associated with the locus are WI-9055, M21896 and U37672 (KLK3); stSG39975 and sts-S39329 (KLK2); WI-20869 (KLK6) and stSG30247 (KLK10) (Harvey et al., 2000) (Figure 1 ). Genomic Southern blot analysis of bacterial artificial chromosomes (BACs) containing DNA from this region, with a degenerate probe to the histidine-encoding region of serine proteases, suggests that most, if not all, serine protease genes in this region have been identified (Harvey et al., 2000) . In support of this, the next gene telomeric of KLK14 is an unrelated gene, SIGLEC9, which encodes a sialic acid-binding Ig-like lectin that is also a member of the immunoglobulin superfamily (Foussias et al., 2000) . However, draft sequence is not yet available for the region centromeric of KLK1 and KLK3, thus there may still be further as yet unidentified genes within the KLK locus.
Structural and Sequence Similarities
The size of the human KLK genes range from 4 -10 kilobases with most of the differences relating to differences in intron sizes, although the intron phases are completely conserved (Luo et al., 1998; Nelson et al., 1999; Stephenson et al., 1999 , Yousef and Diamandis 1999 Yousef et al., 1999b Yousef et al., ,c, 2000a Hu et al., 2000) (Table 2) . Of note, the five coding exons for these serine protease genes are highly conserved both in size and organisation. The first of these has a short 5' untranslated region prior to the initiation of the pre-signal peptide coding region. The second exon encodes the remainder of the pre-as well as pro-enzyme sequences. The mature enzyme is encoded on the remainder of the second coding exon through to the fifth coding exon with a variable sized 3' untranslated region completing this last coding exon. The positions, in the second, third and fifth coding exons, of the three residues of the catalytic triad (histidine, aspartate, serine) critical for protease activity are highly conserved across all 15 genes. Interestingly, this structural organisation is also highly conserved for all rodent KLK genes and the dog KLK2 gene (Evans et al., 1987 , Wines et al., 1989 Chapdelaine et al., 1991) .
The major structural difference between these newer human KLK genes and the original KLK1 -3 genes or those of other species is the presence of additional exons either 5' or 3' of the coding exons for many of these genes (Luo et al., 1998; Hu et al., 2000; Mitsui et al., 2000; Yousef and Diamandis 1999; Yousef et al., 1999b; 200a,c,d,e) . Since the transcriptional start site or TATA box elements have not yet been delineated for all of these genes, it is possible that additional 5' exons may be present in more genes. The mRNA transcript sizes vary from 870 to ~1600 nucleotides with variable 5' and 3' untranslated regions determining the variable length. Both classical (AATAAA) and variant (AGTAAA, ACTAAA, TATAAA, ATTAAA) polyadenylation signals are utilised.
Multiple variant mRNA transcripts, the result of alternative splicing, have also been described for many of the human KLK genes (Chen et al., 1994; Rae et al., 1999; Riegman et al., 1988 Riegman et al., , 1991 Liu et al., 1999; Heuze et al., 1999; Tanaka et al., 2000; Yousef et al., 2000b,d,e; Mitsui et al., 2000) . This is in sharp contrast to the rodent families where only one mRNA transcript has been described for each gene (Evans et al., 1987; Wines et al., 1989) . These splicing events cause a shift in the open reading frame, leading to premature stop codons and truncated proteins 8 J.Clements et al. if translated. These variant transcripts would not encode functional serine proteases as typically one or other of the three residues critical for catalytic activity is missing. The degree of tissue-specificity in expression of these alternatively spliced mRNAs or protein products or their relationship to a particular pathophysiological condition is yet to be determined. Whether these events represent a means of further functional diversification of the human KLK gene family or is a control mechanism for regulating levels of the native protein or is simply an unrelated genomic processing event requires further clarification.
In contrast to the rodent KLK/Klk families and the human KLK1-KLK3 encoded enzymes which are highly conserved (rodents: 70 -85%; K1-K2: 62 -77%), the newer human K4-K15 enzymes are less related (25 -44%) (Figure 2 ). This may reflect an evolutionary order of gene duplication within this locus with the KLK1-KLK3 genes perhaps the result of the most recent duplication. In keeping with this observation, phylogenetic analysis of the human KLK locus suggests that there are a number of sub-groups within this family ( Figure 3 ). As noted above, key residues (and much of the adjacent regions) that denote serine protease activity are entirely conserved (Figure 2 ). The majority of these enzymes are trypsin-like in action, a function denoted by an aspartate six residues before the catalytic serine; four enzymes (K3, K7, K9, K15) have alternate residues in this position which likely denotes a chymotrypsin-like action. Ten of the disulfide bond-forming cysteines are absolutely conserved amongst the 15 kallikreins. A sixth bridge forming cysteine pair is conserved in K4-K12 and K14-K15, but is lacking in K1-K3 and K13 (Figure 2 ). K1-K3 also contain an insertion of 11 amino acids prior to the catalytic aspartate, denoted the kallikrein loop, that is thought to be important for substrate specificity of these enzymes.
The newer proteases do not have this loop region although five of them have smaller insertions (Figure 2 ) that also may be important in specifying their enzymic action.
Tissue-Specific Patterns of Expression
As with the rat KLK family (MacDonald et al., 1996) , the newer members of the human KLK gene family are expressed in a large number of tissues, particularly when expression patterns are examined using the sensitive reverse-transcription-polymerase chain reaction (RT-PCR) (Brattsand and Egelrud, 1999; Diamandis 1999, 2000; Yousef et al., 1999b Yousef et al., ,c, 2000b Harvey et al., 2000) (Table 1) . However, the number of tissues in which they are most highly expressed, as delineated using Northern and mRNA dot blot analysis, is more restricted and surprisingly conserved. In comparison to the well described KLK1 gene, that is highly expressed in the salivary gland, kidney and pancreas (Baker and Shine, 1985; Fukushima et al., 1985; Evans et al., 1988) , no other genes exhibit that precise pattern of expression, although, the KLK6 gene is highly expressed in the brain, kidney and pancreas (Anisowicz et al., 1996; Little et al., 1997; Harvey et al., 2000) . Additionally, several other genes are highly expressed in the pancreas (KLK7 -13; Liu et al., 1996; Harvey et al., 2000) . Of interest is the clustering of these eight genes within the locus perhaps indicating conservation of promoter elements conferring tissue specific expression or a common locus control region. Indeed, a pancreatic-specific-like sequence similar to that identified in other rat pancreatic serine proteases (Swift et al., 1984; Boulet et al., 1986) has been identified in the promoter of the rodent and human KLK1 genes (Wines et al., 1989) .
The Expanded Human KLK Gene Family 9 Furthermore, the KLK4 gene exhibits an identical expression pattern to that of the previously characterised KLK2 and KLK3 genes with abundant expression restricted to the prostate (Chapdelaine et al., 1988; Riegman et al., 1988; Nelson et al., 1999; Stephenson et al., 1999 , Harvey et al., 2000 . KLK2 -4 are clustered together in the locus and the promoters of KLK2 and KLK3 have been extensively characterised and show a high degree of conservation (Wolf et al., 1992; Murtha et al., 1993; Cleutjens et al., 1997; Sun et al., 1997) . By Northern and mRNA dot blot analysis, other tissues in which KLK expression is abundant are the brain (KLK8, KLK11, KLK14), skin (KLK5, KLK7, KLK8, KLK11), lung (KLK10, KLK11), heart (KLK11), testis (KLK5, KLK10, KLK11), mammary gland (KLK5, KLK10), ovary, small intestine and colon (KLK10) (Anisowicz et al., 1996; Liu et al., 1996; Yoshida et al., 1998; Brattsand and Egelrud, 1999; Harvey et al., 2000; Mitsui et al., 2000) . KLK5, KLK6, KLK8, KLK10 are also expressed at high levels, at the mRNA level, in ovarian or breast cancer carcinomas or cell lines (Anisowicz et al., 1996; Liu et al., 1996; Tanimoto et al., 1999; Underwood et al., 1999) . In addition to these sites Residues which are identical between at least eight of the enzymes are boxed. Catalytic residues are indicated by filled boxes. Disulfide bond forming cysteines are indicated by filled circles. The residue located at the bottom of the substrate binding pocket is indicated by a circle. The kallikrein loop region is overlined. The activation site is indicated by a filled triangle. The alignment was performed using the PileUp program. GenBank accession numbers: K1, M33105; K2, M18157; K3, M26663; K4, AF148532; K5, AF135028; K6, U62801; K7, L33404; K8, AB009849; K9, AF135026; K10, AF024605; K11, AB012917; K12, AF135025; K13, AF135024; K14, AF283669; K15, AF242195.
of high expression, RT-PCR analysis demonstrates that these newer KLK genes are also expressed in a range of other tissues including salivary gland, trachea, esophagus, spinal cord, thymus, appendix, spleen, bone marrow, adrenal gland, thyroid, uterus, placenta and fetal organs as well as several carcinoma cell lines (Brattsund and Egelrud, 1999; Diamandis, 1999, 2000; Yousef et al., 1999a-c; 2000b-e; Harvey et al., 2000) .
Known and Putative Functions
From the combined Northern blot and RT-PCR data, it is clear that this family of genes is expressed to varying degrees in a large number of tissues and are likely to be important in a diverse range of patho(physiological) processes. The roles of the first three KLK family members to be identified -tissue kallikrein or K1, K2 and PSA -are well described. Tissue kallikrein, through the generation of (lys)bradykinin, and a ubiquitous expression pattern, is involved in the function of most systems in the body (Bhoola et al., 1992; Clements, 1997) . There is some in vitro evidence that tissue kallikrein may act on a range of other substrates such as the matrix metalloproteases (Tschesche et al., 1989) , but these are not proven biological functions. PSA hydrolyses seminal vesicle proteins in ejaculate, an event that is integral to sperm motility (Lilja, 1985) . Like tissue kallikrein, PSA is also suggested to act on several other substrates (Rittenhouse et al., 1998) but the biological relevance of these findings is not yet clear. PSA is widely used as a diagnostic marker for prostate cancer and monitoring tumour recurrence (Frydenberg et al., 1997) . Of interest, PSA expression is also associated with breast disease (Yu et al., 1996) and PSA has been recently suggested to be a useful prognostic marker for breast cancer (Black and Diamandis, 2000) . K2, to a lesser degree, is also being examined as a diagnostic/prognostic marker for prostate disease (Young et al., Recker et al., 1998) . K2 activates pro-urinary plasminogen activator and thus plays a role in matrix degradation and cancer invasion (Frenette et al., 1997) . K2 can also activate pro-PSA (Lovgren et al., 1997; Kumar et al., 1997; Takayama et al., 1997) , demonstrating the close relationship of these two prostatic kallikreins.
The enzymatic functions of nearly all of the newer KLKencoded proteins are not yet known. The exception is K6 or zyme that can hydrolyse amyloid precursor protein and thus is hypothesised to be important in the deposition of amyloid plaques in Alzheimer's disease (Little et al., 1997) . Interestingly, the KLK6 gene is also highly expressed in breast and ovarian cancers (Anisowicz et al., 1996; Yousef et al., 1999b) . Although the function of K6 in these malignancies is yet to be established, these findings highlight the potential for diverse, perhaps tissuespecific, roles for these enzymes. As noted above, the expression of several other KLK genes in breast, ovarian and prostate cancer tissues or cell lines (Anisowicz et al., 1996; Nelson et al., 1999; Tanimoto et al., 1999; Underwood et al., 1999; Diamandis, 1999, 2000; Yousef et al., 1999b, c; 2000b-e; Gan et al., 2000; Harvey et al., 2000) demonstrates that many members of this family of serine proteases are associated with hormonedependent cancers . Whether these enzymes, like PSA and K2, may be useful diagnostic or prognostic markers for these diseases or play important roles in cancer progression is yet to be established. Interestingly, KLK10 is suggested to play a tumour suppressor role in breast and prostate cancer (Goyal et al., 1998) .
Similarly, the isolation or cloning of these enzymes from specific tissues such as the skin (KLK5, KLK7, KLK11) and brain (KLK6, KLK8, KLK11) suggests a role at these sites, although this is yet to be elucidated. Several of these genes (KLK5, KLK6, KLK9) are also expressed in psoriatic lesions further emphasising their involvement in the (patho)physiology of the skin (Gan et al., 2000) . Of interest, in a manner analagous to that of the prostatic K2 and PSA enzymes, the co-localisation of the trypsin-like K5 and chymotrypsin-like K7 enzymes in skin has led to the proposal that K5 may be the activator of K7 in this tissue (Brattsand and Egelrud, 1999) . As noted above, the high expression of the KLK6-KLK13 cluster in the pancreas (Harvey et al., 2000) presumably also suggests an important role in pancreatic function for these enzymes. Other functions, in teeth development and neural plasticity, have been suggested for the K4 and K8 enzymes respectively, by extrapolation of the known actions of their putative mouse orthologues -enamel matrix serine protease and neuropsin (Hu et al., 2000; Yoshida et al., 1998) .
The Expanded Human KLK Gene Family 11 Fig. 3 Phylogenetic Tree of the Expanded KLK Family. The tree was generated from an Eclustal multiple sequence alignment of the 15 kallikrein proteins using the Dayhoff program of the Phylip package. The lower the branch number the more closely related the genes.
Conclusion
The expanded human KLK serine proteases, although encoded by a large multigene family as in rodents, are less conserved than their rodent counterparts. Their largely disparate but overlapping expression patterns indicate that these enzymes are likely to be involved in the (patho)physiology of a range of different organs. The challenge now is to precisely determine the enzymic action of these proteases and their biological roles in these tissues and to assess their viability as diagnostic markers for a number of disease states.
